CIK 0000882095 · Large accelerated filer
GILEAD SCIENCES, INC.
Sign in to watch- Ticker
- GILD
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 943047598
- Phone
- 6505743000
- Business address
- 333 LAKESIDE DR, FOSTER CITY, CA, 94404
- Former names
- GILEAD SCIENCES INC
- 144 Insider Sale of Securities
- 4 Shares withheld for taxes Chief Financial Officer gave up 1,347 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Medical Officer gave up 263 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Comm & Corp Aff Officer gave up 1,347 shares (to pay taxes)
- 4 Shares withheld for taxes EVP Gen Counsel, Legal & Comp gave up 285 shares (to pay taxes)
- 4 Shares withheld for taxes Chairman & CEO gave up 4,230 shares (to pay taxes)
- 4 Planned sale Chairman & CEO sold 15,000 shares at an average $148.64 ($2,229,592)
- 4 Planned sale Director sold 18,000 shares at an average $148.62 ($2,675,220)
- 144 Insider Sale of Securities
- N-PX Other Annual Proxy Voting Report
- 4 Planned sale Director sold 5,000 shares at an average $145.02 ($725,078)
- 144 Insider Sale of Securities
- 4 Planned sale Chief Financial Officer sold 3,000 shares at $138.36 ($415,080)
- 4 Planned sale Chief Comm & Corp Aff Officer sold 28,000 shares at an average $137.64 ($3,853,908)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Shares withheld for taxes EVP Gen Counsel, Legal & Comp gave up 2,908 shares (to pay taxes)
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- S-3ASR Offering Registration Statement
- 10-Q Report Quarterly Report
Page 2 of 160 · 3,186 filings